Table 1 Clinical characteristics of the study population (n = 77).
| Demographics | |
| Age (years) | 64 (11) |
| Gender (male) | 69 (90%) |
| Clinical data | |
| Diabetes mellitus | 18 (23%) |
| Hypertension | 29 (38%) |
| Previous coronary revascularisation | 24 (31%) |
| Heart failure | 58 (75%) |
| NYHA class | 1.8 (0.8) |
| Angina pectoris | 53 (69%) |
| β‐blocker therapy | 58 (75%) |
| ACE inhibitor/angiotensin receptor blocker therapy | 62 (81%) |
| Coronary disease | |
| Coronary angiography | 60 (78%) |
| Single‐vessel disease | 19/60 (31%) |
| Multi‐vessel disease | 41/60 (69%) |
| ECG | |
| QRS duration (ms) | 109 (26) |
| QRS duration >100 ms | 36 (47%) |
| QRS duration >120 ms | 22 (29%) |
| LBBB | 18 (23%) |
| 2D echocardiography | |
| LVEDVI (ml) | 91 (35) |
| LVESVI (ml) | 59 (30) |
| LVEF (%) | 37 (12) |
LBBB, left bundle branch block; LVEDVI, left ventricular end‐diastolic volume index; LVEF, left ventricular ejection fraction; LVESVI, left ventricular end‐systolic volume index; NYHA, New York Heart Association.